ENLARGED PROSTATE TREATMENT STUDY SHOWS COMBINATION OF AVODART(R) AND TAMSULOSIN PROVIDES GREATER BENEFIT THAN EITHER MEDICATION Journal of Urology Publishes CombAT Study Results Information provided by newsfeed service. |
![]() |
PHILADELPHIA, Jan. 18 /PRNewswire/ -- A study to be published in the February issue of the Journal of Urology shows that men with enlarged prostates who took a combination of two medications, AVODART (dutasteride) and tamsulosin, experienced significantly greater improvement in urinary symptoms than men prescribed either medication alone, GlaxoSmithKline said today.
The publication will mark the first time the full two-year results of the CombAT (Combination of Avodart and Tamsulosin) study, one of the largest clinical trials to date of men with enlarged prostate, have appeared in a major medical journal.(1) Topline results were previously presented in September 2007 at the annual meeting of the Societe Internationale d'Urologie in Paris.
The full text of this article is available here from ADVFN.